Predictive Diagnostics Market

Predictive Diagnostics Market By Test (PCR based, NGS (sequencing) based), By Indication (Cancer, Metabolic Disorders, Neurological Disorders, Musculoskeletal Diseases), By End User, By Region - Global Market Insights 2021 to 2031

Analysis of Predictive Diagnostics Market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

author

Author:

Md Sanaullah

author

Editor:

Anushree Karale

Predictive Diagnostics Market
  • FACT5509MR
  • 09 Feb 2021
  • Healthcare
  • 170 Pages
  • 32 Tables
  • 167 Figures

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Market Background
  • 5. Market Context
  • 6. Global Value Analysis 2016 to 2020 and Forecast, 2021 to 2031
  • 7. Global Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type
    • 7.1. PCR based
    • 7.2. NGS (sequencing) based
  • 8. Global Analysis 2016 to 2020 and Forecast 2021 to 2031, by Indication
    • 8.1. Cancer
    • 8.2. Metabolic disorders
    • 8.3. Neurological disorders
    • 8.4. Musculoskeletal diseases
    • 8.5. Others
  • 9. Global Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User
    • 9.1. Diagnostics
    • 9.2. Genetic Laboratories And Clinics
    • 9.3. Research And Academic Institutes
  • 10. Global Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region
    • 10.1. North America
    • 10.2. Latin America
    • 10.3. Europe
    • 10.4. East Asia
    • 10.5. South Asia
    • 10.6. Oceania
    • 10.7. Middle East and Africa (MEA)
  • 11. North America Analysis 2016 to 2020 and Forecast 2021 to 2031
  • 12. Latin America Analysis 2016 to 2020 and Forecast 2021 to 2031
  • 13. Europe Analysis 2016 to 2020 and Forecast 2021 to 2031
  • 14. South Asia Analysis 2016 to 2020 and Forecast 2021 to 2031
  • 15. East Asia Analysis 2016 to 2020 and Forecast 2021 to 2031
  • 16. Oceania Analysis 2016 to 2020 and Forecast 2021 to 2031
  • 17. Middle East and Africa Analysis 2016 to 2020 and Forecast 2021 to 2031
  • 18. Key and Emerging Countries Analysis 2016 to 2020 and Forecast 2021 to 2031
  • 19. Market Structure Analysis
  • 20. Competition Analysis
    • 20.1. Qiagen
    • 20.2. Therawis
    • 20.3. Myriad Genetics, Inc.
    • 20.4. BIOMÉRIEUX SA
    • 20.5. Hoffmann-La Roche
    • 20.6. Thermo Fisher Scientific
    • 20.7. Bio-Rad
    • 20.8. Centogene N.V.
    • 20.9. Predictive Oncology
    • 20.10. Mylab Discovery Solutions Pvt. Ltd.
  • 21. Assumptions and Acronyms Used
  • 22. Research Methodology

List Of Table

Table 01: Global Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Table 02: Global Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication

Table 03: Global Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Table 04: Global Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Region

Table 05: North America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country

Table 06: North America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Table 07: North America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication

Table 08: North America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Table 09: Latin America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country

Table 10: Latin America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Table 11: Latin America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication

Table 12: Latin America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Table 13: Europe Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country

Table 14: Europe Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Table 15: Europe Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication

Table 16: Europe Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Table 17: East Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country

Table 18: East Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Table 19: East Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication

Table 20: East Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Table 21: South Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country

Table 22: South Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Table 23: South Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication

Table 24: South Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Table 25: Oceania Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country

Table 26: Oceania Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Table 27: Oceania Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication

Table 28: Oceania Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Table 29: MEA Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country

Table 30: MEA Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Table 31: MEA Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Indication

Table 32: MEA Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

List Of Figures

Figure 01: Global Size (US$ Mn) Analysis, 2016 to 2020

Figure 02: Global Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021 to 2031

Figure 03: Global Absolute $ Opportunity Analysis, 2021 to 2031

Figure 04: Global Analysis by Test Type to 2021 & 2031

Figure 05: Global Y-o-Y Growth Projections by Test Type, 2021 to 2031

Figure 06: Global Attractiveness Analysis By Test Type, 2021 to 2031

Figure 07: Global Analysis by Indication to 2021 & 2031

Figure 08: Global Y-o-Y Growth Projections by Indication, 2021 to 2031

Figure 09: Global Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Indication

Figure 10: Global Analysis by End User to 2021 & 2031

Figure 11: Global Y-o-Y Growth Projections by End User , 2021 to 2031

Figure 12: Global Attractiveness Analysis 2021 to 2031, By End User

Figure 13: Global Share Analysis (%) By Region, 2021 & 2031

Figure 14: Global Y-o-Y Growth (%) By Region, 2021 to 2031

Figure 15: Global Attractiveness Analysis 2021 to 2031, By Region

Figure 16: North America Size (US$ Mn) Analysis, 2016 to 2020

Figure 17: North America Size (US$ Mn) & Y-o-Y Growth (%), 2021 to 2031

Figure 18: North America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Country

Figure 19: North America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Figure 20: North America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, Indication

Figure 21: North America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Figure 22: Latin America Size (US$ Mn) Analysis, 2016 to 2020

Figure 23: Latin America Size (US$ Mn) & Y-o-Y Growth (%), 2021 to 2031

Figure 24: Latin America Medical America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Country

Figure 25: Latin America Medical America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Figure 26: Latin America Medical America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, Indication

Figure 27: Latin America Medical America Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Figure 28: Europe Size (US$ Mn) Analysis, 2016 to 2020

Figure 29: Europe Size (US$ Mn) & Y-o-Y Growth (%), 2021 to 2031

Figure 30: Europe Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Country

Figure 31: Europe Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Figure 32: Europe Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, Indication

Figure 33: Europe Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Figure 34: East Asia Size (US$ Mn) Analysis, 2016 to 2020

Figure 35: East Asia Size (US$ Mn) & Y-o-Y Growth (%), 2021 to 2031

Figure 36: East Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Country

Figure 37: East Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Figure 38: East Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, Indication

Figure 39: East Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Figure 40: South Asia Size (US$ Mn) Analysis, 2016 to 2020

Figure 41: South Asia Size (US$ Mn) & Y-o-Y Growth (%), 2021 to 2031

Figure 42: South Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Country

Figure 43: South Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Figure 44: South Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, Indication

Figure 45: South Asia Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Figure 46: Oceania Size (US$ Mn) Analysis, 2016 to 2020

Figure 47: Oceania Size (US$ Mn) & Y-o-Y Growth (%), 2021 to 2031

Figure 48: Oceania Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Country

Figure 49: Oceania Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Figure 50: Oceania Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, Indication

Figure 51: Oceania Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Figure 52: MEA Size (US$ Mn) Analysis, 2016 to 2020

Figure 53: MEA Size (US$ Mn) & Y-o-Y Growth (%), 2021 to 2031

Figure 54: MEA Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Country

Figure 55: MEA Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by Test Type

Figure 56: MEA Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, Indication

Figure 57: MEA Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

Figure 58: China Market Value Proportion Analysis, 2021

Figure 59: China Share Analysis (%) By Test Type, 2021 & 2031

Figure 60: China. Share Analysis (%) By Indication, 2021 & 2031

Figure 61: China. Share Analysis (%) By End User, 2021 & 2031

Figure 62: Global Vs. China Growth Comparison

Figure 63: India Market Value Proportion Analysis, 2021

Figure 64: India. Share Analysis (%) By Test Type, 2021 & 2031

Figure 65: India. Share Analysis (%) By Indication, 2021 & 2031

Figure 66: India. Share Analysis (%) By End User, 2021 & 2031

Figure 67: Global Vs. India Growth Comparison

Figure 68: Brazil Market Value Proportion Analysis, 2021

Figure 69: Brazil. Share Analysis (%) By Test Type, 2021 & 2031

Figure 70: Brazil. Share Analysis (%) By Indication, 2021 & 2031

Figure 71: Brazil. Share Analysis (%) By End User, 2021 & 2031

Figure 72: Global Vs. Brazil Growth Comparison

Figure 73: U.S Market Value Proportion Analysis, 2021

Figure 74: U.S. Share Analysis (%) By Test Type, 2021 & 2031

Figure 75: U.S. Share Analysis (%) By Indication, 2021 & 2031

Figure 76: U.S. Share Analysis (%) By End User, 2021 & 2031

Figure 77: Global Vs. U.S Growth Comparison

Figure 78: Canada Market Value Proportion Analysis, 2021

Figure 79: Canada Share Analysis (%) By Test Type, 2021 & 2031

Figure 80: Canada Share Analysis (%) By Indication, 2021 & 2031

Figure 81: Canada Share Analysis (%) By End User, 2021 & 2031

Figure 82: Global Vs. Canada Growth Comparison

Figure 83: Mexico Market Value Proportion Analysis, 2021

Figure 84: Mexico Share Analysis (%) By Test Type, 2021 & 2031

Figure 85: Mexico Share Analysis (%) By Indication, 2021 & 2031

Figure 86: Mexico Share Analysis (%) By End User, 2021 & 2031

Figure 87: Global Vs. Mexico Growth Comparison

Figure 88: Argentina Market Value Proportion Analysis, 2021

Figure 89: Argentina Share Analysis (%) By Test Type, 2021 & 2031

Figure 90: Argentina Share Analysis (%) By Indication, 2021 & 2031

Figure 91: Argentina Share Analysis (%) By End User, 2021 & 2031

Figure 92: Global Vs. Argentina Growth Comparison

Figure 93: U.K. Market Value Proportion Analysis, 2021

Figure 94: U.K. Share Analysis (%) By Test Type, 2021 & 2031

Figure 95: U.K. Share Analysis (%) By Indication, 2021 & 2031

Figure 96: U.K. Share Analysis (%) By End User, 2021 & 2031

Figure 97: Global Vs. U.K Growth Comparison

Figure 98: Germany Market Value Proportion Analysis, 2021

Figure 99: Germany Share Analysis (%) By Test Type, 2021 & 2031

Figure 100: Germany Share Analysis (%) By Indication, 2021 & 2031

Figure 101: Germany Share Analysis (%) By End User, 2021 & 2031

Figure 102: Global Vs. Germany Growth Comparison

Figure 103: France Market Value Proportion Analysis, 2021

Figure 104: France Share Analysis (%) By Test Type, 2021 & 2031

Figure 105: France Share Analysis (%) By Indication, 2021 & 2031

Figure 106: France Share Analysis (%) By End User, 2021 & 2031

Figure 107: Global Vs. France Growth Comparison

Figure 108: Italy Market Value Proportion Analysis, 2021

Figure 109: Italy Share Analysis (%) By Test Type, 2021 & 2031

Figure 110: Italy Share Analysis (%) By Indication, 2021 & 2031

Figure 111: Italy Share Analysis (%) By End User, 2021 & 2031

Figure 112: Global Vs. Italy Growth Comparison

Figure 113: Spain Market Value Proportion Analysis, 2021

Figure 114: Spain Share Analysis (%) By Test Type, 2021 & 2031

Figure 115: Spain Share Analysis (%) By Indication, 2021 & 2031

Figure 116: Spain Share Analysis (%) By End User, 2021 & 2031

Figure 117: Global Vs. Spain Growth Comparison

Figure 118: Russia Market Value Proportion Analysis, 2021

Figure 119: Russia Share Analysis (%) By Test Type, 2021 & 2031

Figure 120: Russia Share Analysis (%) By Indication, 2021 & 2031

Figure 121: Russia Share Analysis (%) By End User, 2021 & 2031

Figure 122: Global Vs. Russia Growth Comparison

Figure 123: Japan Market Value Proportion Analysis, 2021

Figure 124: Japan Share Analysis (%) By Test Type, 2021 & 2031

Figure 125: Japan Share Analysis (%) By Indication, 2021 & 2031

Figure 126: Japan Share Analysis (%) By End User, 2021 & 2031

Figure 127: Global Vs. Japan Growth Comparison

Figure 128: South Korea Market Value Proportion Analysis, 2021

Figure 129: South Korea Share Analysis (%) By Test Type, 2021 & 2031

Figure 130: South Korea Share Analysis (%) By Indication, 2021 & 2031

Figure 131: South Korea Share Analysis (%) By End User, 2021 & 2031

Figure 132: Global Vs. South Korea Growth Comparison

Figure 133: Indonesia Market Value Proportion Analysis, 2021

Figure 134: Indonesia Share Analysis (%) By Test Type, 2021 & 2031

Figure 135: Indonesia Share Analysis (%) By Indication, 2021 & 2031

Figure 136: Indonesia Share Analysis (%) By End User, 2021 & 2031

Figure 137: Global Vs. Indonesia Growth Comparison

Figure 138: Malaysia Market Value Proportion Analysis, 2021

Figure 139: Malaysia Share Analysis (%) By Test Type, 2021 & 2031

Figure 140: Malaysia Share Analysis (%) By Indication, 2021 & 2031

Figure 141: Malaysia Share Analysis (%) By End User, 2021 & 2031

Figure 142: Global Vs. Malaysia Growth Comparison

Figure 143: Thailand Market Value Proportion Analysis, 2021

Figure 144: Thailand Share Analysis (%) By Test Type, 2021 & 2031

Figure 145: Thailand Share Analysis (%) By Indication, 2021 & 2031

Figure 146: Thailand Share Analysis (%) By End User, 2021 & 2031

Figure 147: Global Vs. Thailand Growth Comparison

Figure 148: Australia Market Value Proportion Analysis, 2021

Figure 149: Australia Share Analysis (%) By Test Type, 2021 & 2031

Figure 150: Australia Share Analysis (%) By Indication, 2021 & 2031

Figure 151: Australia Share Analysis (%) By End User, 2021 & 2031

Figure 152: Global Vs. Australia Growth Comparison

Figure 153: New Zealand Market Value Proportion Analysis, 2021

Figure 154: New Zealand Share Analysis (%) By Test Type, 2021 & 2031

Figure 155: New Zealand Share Analysis (%) By Indication, 2021 & 2031

Figure 156: New Zealand Share Analysis (%) By End User, 2021 & 2031

Figure 157: Global Vs. New Zealand Growth Comparison

Figure 158: South Africa Market Value Proportion Analysis, 2021

Figure 159: South Africa Share Analysis (%) By Test Type, 2021 & 2031

Figure 160: South Africa Share Analysis (%) By Indication, 2021 & 2031

Figure 161: South Africa Share Analysis (%) By End User, 2021 & 2031

Figure 162: Global Vs. South Africa Growth Comparison

Figure 163: GCC Countries Market Value Proportion Analysis, 2021

Figure 164: GCC Countries Share Analysis (%) By Test Type, 2021 & 2031

Figure 165: GCC Countries Share Analysis (%) By Indication, 2021 & 2031

Figure 166: GCC Countries Share Analysis (%) By End User, 2021 & 2031

Figure 167: Global Vs. GCC Countries Growth Comparison

Predictive Diagnostics Market